These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2477896)
41. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker. Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433 [TBL] [Abstract][Full Text] [Related]
42. Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer. Tsurusaki T; Koji T; Sakai H; Kanetake H; Saito Y Clin Cancer Res; 1998 Sep; 4(9):2187-94. PubMed ID: 9748138 [TBL] [Abstract][Full Text] [Related]
43. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Bremnes RM; Sirera R; Camps C Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585 [TBL] [Abstract][Full Text] [Related]
45. Comparison between various tumor marker. Pastore M; Sbaffi A; Francioni S; Castellaro E J Nucl Med Allied Sci; 1990; 34(4 Suppl):239-50. PubMed ID: 2092126 [No Abstract] [Full Text] [Related]
46. A proteolipid in cancer cells is the origin of their high-resolution NMR spectrum. Wright LC; May GL; Dyne M; Mountford CE FEBS Lett; 1986 Jul; 203(2):164-8. PubMed ID: 3732508 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. Wieczorek AJ; Sitaramam V; Machleidt W; Rhyner K; Perruchoud AP; Block LH Cancer Res; 1987 Dec; 47(23):6407-12. PubMed ID: 2445471 [TBL] [Abstract][Full Text] [Related]
48. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Schmidt B; Engel E; Carstensen T; Weickmann S; John M; Witt C; Fleischhacker M Lung Cancer; 2005 Apr; 48(1):145-7. PubMed ID: 15777983 [TBL] [Abstract][Full Text] [Related]
49. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Kopreski MS; Benko FA; Gocke CD Ann N Y Acad Sci; 2001 Sep; 945():172-8. PubMed ID: 11708475 [TBL] [Abstract][Full Text] [Related]
50. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic potential of circulating nucleic acids for oncology. Goessl C Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383 [TBL] [Abstract][Full Text] [Related]